LAB Stock Analysis: Buy, Sell, or Hold?
LAB - Standard BioTools Inc. Common Stock
$1.03
-0.01 (-0.96%)
▼
5d:
+4.59%
30d:
+15.23%
90d:
-7.21%
BUY
MODERATE Confidence
Analysis Updated: May 22, 2026 12:00 AM ET
Earnings: May 12, 2026
0d
Get Alerted When LAB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called LAB this week
0% bullish • 1 bearish
0% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: LAB shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: LAB shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: LAB is currently trading at $1.03, which is considered extended relative to its 30-day fair value range of $0.91 to $1.01.
Technical Outlook: Technically, LAB is in a strong downtrend. The price is approaching resistance at $1.06. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: LAB has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $1.55 (+50.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, LAB is in a strong downtrend. The price is approaching resistance at $1.06. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: LAB has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $1.55 (+50.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.91 -
$1.01
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 50.5% below Wall St target ($1.55)
Trading Range Analysis
30-Day Trading Range
$0.91 -
$1.01
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.97
Resistance Level
$1.06
Current Trend
Strong Downtrend
Technical data as of
May 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-103.00
Wall Street Target
$1.55
(+50.5%)
Revenue Growth (YoY)
4.6%
Profit Margin
90.7%
Share & Embed Analysis
Last updated: May 25, 2026 3:33 AM ET
Data refreshes hourly during market hours. Next update: 4:33 AM
Data refreshes hourly during market hours. Next update: 4:33 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LAB showing a specific setup today?
Insider Activity (6 Months)
3
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Casdin Partners Master F…
BUY
150000 shares
2025-12-04
Casdin Partners Master F…
BUY
75000 shares
2025-12-03
Casdin Partners Master F…
BUY
125000 shares
2025-12-02
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$83 | 62 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$82 | 64 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$119 | 62 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$107 | 62 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 67 BUY |
Advanced LAB Option Strategies
Professional options setups generated by AI based on today's LAB price and gamma walls.
